« Previous
Next »
Thrombosis Research
Volume 126, Issue 2
, Pages 103-106
, August 2010
Haemostatic profile of healthy premature small for gestational age neonates
References
- . Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340:1234–1238
- . Israel Neonatal Network. Excess mortality and morbidity among small-for-gestational-age premature infants: a population based study. J Pediatr. 2003;143:186–191
- . Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction: the Vermont Oxford Network. Am J Obstet Gynecol. 2000;182:198–206
- . Increased morbidity in severe early intrauterine growth restriction. J Perinatol. 2004;24:435–440
- No improvement in outcome of nationwide extremely low birthweight infant populations between 1996-7 and 1999-2000. Pediatrics. 2007;119:29–36
- . Thromboembolic Disease and Antithrombotic Therapy in Newborns. Hematology. 2001;358–374
- . The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol. 2002;119(2):295–309
- . The IUGR newborn. Semin Perinatol. 2008;32(3):219–224
- . Persistent antithrombin III deficiency: risk factor for thromboembolic complications in neonates small for gestational age. J Pediatr. 1984;105(2):310–314
- Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants. Arch Dis Child Fetal Neonatal Ed. 2003;88(4):F319–F323
- . Perinatal Stroke in Children With Motor Impairment: A Population-Based Study. Pediatrics. 2004;114:612–619
- . Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed. 2004;89:475–478
- . Development of hemostasis in the fetus. Thromb Res. 2005;115(Sl1):55–63
- Development of the human coagulation system in the full-term infant. Blood. 1987;70(1):165–172
- Development of the human coagulation system in the healthy premature infant. Blood. 1988;72(5):1651–1657
- Developmental Haemostasis: Impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95:362–372
- . The importance of hematocrit in the interpretation of coagulation tests in the full-term newborn infant. Haematologica. 1994;79(1):25–28
- . Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood. 1996;88(3):900–906
- Haemostatic profile of full-term, healthy, small for gestational age neonates. Thromb Res. 2009;124(3):288–291
- . Report of Scientific and Standardization Subcommittee on Neonatal Haemostasis. Normal coagulation data for fetuses and newborn infants. Thromb Haemost. 1991;65:323–325
- . Hemostasis in neonates and children: Pitfalls and dilemmas. Blood Rev. 2010;24:63–68
- . 1994–1996 U.S. Singleton Birth Weight Percentiles for Gestational Age by Race, Hispanic Origin, and Gender. Matern Child Health J. 1999;3(4):225–231
- . Neonatal thromboembolic emergencies. Semin Fetal Neonatal Med. 2006;11:198–206
- . Effect of antihemophilic factor on one-stage clotting tests. J Lab Clin Med. 1953;41:637–647
- . Utilisation de la “céphaline” dans les tests. Nouv Rev Fr Hématol. 1957;12:199–210
- . Vitamin K1 in plasma: relationship to vitamin K status, age, pregnancy, diet and disease. Haemostasis. 1986;16(5):83
- . Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst Rev. 2000;CD002776
- Role of coagulopathy in newborn intracranial hemorrhage. Pediatrics. 1984;74:26–31
- . Committee on Fetus and Newborn Controversies concerning Vitamin K and the newborn. Pediatrics. 2003;112:191–192
- . Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep- vein thrombosis. Lancet. 1995;345:152–155
- . Elevation of factor VIII in hypercoagulable states. Thromb Diath Haemorrh. 1966;39–48(SV)
- . Development of resistance to activated protein C during pregnancy. Br J Haematol. 1995;90:725–727
- . The Glasgow outcome, APCR and Lipid (GOAL) pregnancy study: significance of pregnancy associated activated protein. Thromb Haemost. 2001;85:30–35
- . Role of endothelium in thrombosis and hemostasis. Annu Rev Med. 1996;47:315
- . Endothelium in hemostasis and thrombosis. Prog Cardiovasc Dis. 1997;39:343
- . Plasminogen activator inhibitors. Blood. 1987;69:381
- . Pharmacokinetics and effects of fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteers. Thromb Haemost. 1986;56
PII: S0049-3848(10)00293-8
doi: 10.1016/j.thromres.2010.05.010
© 2010 Elsevier Ltd. All rights reserved.
« Previous
Next »
Thrombosis Research
Volume 126, Issue 2
, Pages 103-106
, August 2010
